Literature DB >> 25505250

A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.

Nadra J Nilsen1, Gregory I Vladimer2, Jørgen Stenvik3, M Pontus A Orning4, Maria V Zeid-Kilani3, Marit Bugge3, Bjarte Bergstroem3, Joseph Conlon2, Harald Husebye3, Amy G Hise5, Katherine A Fitzgerald4, Terje Espevik6, Egil Lien7.   

Abstract

Toll-like receptors (TLRs) are involved in sensing invading microbes by host innate immunity. TLR2 recognizes bacterial lipoproteins/lipopeptides, and lipopolysaccharide activates TLR4. TLR2 and TLR4 signal via the Toll/interleukin-1 receptor adaptors MyD88 and MAL, leading to NF-κB activation. TLR4 also utilizes the adaptors TRAM and TRIF, resulting in activation of interferon regulatory factor (IRF) 3. Here, we report a new role for TRAM and TRIF in TLR2 regulation and signaling. Interestingly, we observed that TLR2-mediated induction of the chemokine Ccl5 was impaired in TRAM or TRIF deficient macrophages. Inhibition of endocytosis reduced Ccl5 release, and the data also suggested that TRAM and TLR2 co-localize in early endosomes, supporting the hypothesis that signaling may occur from an intracellular compartment. Ccl5 release following lipoprotein challenge additionally involved the kinase Tbk-1 and Irf3, as well as MyD88 and Irf1. Induction of Interferon-β and Ccl4 by lipoproteins was also partially impaired in cells lacking TRIF cells. Our results show a novel function of TRAM and TRIF in TLR2-mediated signal transduction, and the findings broaden our understanding of how Toll/interleukin-1 receptor adaptor proteins may participate in signaling downstream from TLR2.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Innate Immunity; Interferon; Interferon Regulatory Factor (IRF); Macrophage; TIR Domain-containing Adaptor-inducing Interferon-B (TRIF); Toll-like Receptor (TLR); Toll-like Receptor 2 (TLR2); Toll-like Receptor Adaptor Molecule 2

Mesh:

Substances:

Year:  2014        PMID: 25505250      PMCID: PMC4318996          DOI: 10.1074/jbc.M114.593426

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Hideki Sanjo; Satoshi Uematsu; Tsuneyasu Kaisho; Katsuaki Hoshino; Osamu Takeuchi; Masaya Kobayashi; Takashi Fujita; Kiyoshi Takeda; Shizuo Akira
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

2.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.

Authors:  Dong-chul Kang; Rahul V Gopalkrishnan; Qingping Wu; Eckhard Jankowsky; Anna Marie Pyle; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription.

Authors:  M Bonnard; C Mirtsos; S Suzuki; K Graham; J Huang; M Ng; A Itié; A Wakeham; A Shahinian; W J Henzel; A J Elia; W Shillinglaw; T W Mak; Z Cao; W C Yeh
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

4.  Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage.

Authors:  Yan-Chun Wang; Yu Zhou; Huang Fang; Sen Lin; Peng-Fei Wang; Ren-Ping Xiong; Jing Chen; Xiao-Yi Xiong; Feng-Lin Lv; Qiao-Li Liang; Qing-Wu Yang
Journal:  Ann Neurol       Date:  2014-05-28       Impact factor: 10.422

5.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

6.  Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions.

Authors:  Hongmei Yang; Charles H Lin; Gang Ma; Melissa Orr; Michael O Baffi; Marc G Wathelet
Journal:  Eur J Biochem       Date:  2002-12

7.  Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes.

Authors:  T Kawai; O Takeuchi; T Fujita; J Inoue; P F Mühlradt; S Sato; K Hoshino; S Akira
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

8.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

9.  Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction.

Authors:  Eicke Latz; Alberto Visintin; Egil Lien; Kate A Fitzgerald; Brian G Monks; Evelyn A Kurt-Jones; Douglas T Golenbock; Terje Espevik
Journal:  J Biol Chem       Date:  2002-09-24       Impact factor: 5.157

10.  Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus.

Authors:  S Morath; A Geyer; T Hartung
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  46 in total

1.  Adaptor Protein-3-Mediated Trafficking of TLR2 Ligands Controls Specificity of Inflammatory Responses but Not Adaptor Complex Assembly.

Authors:  Tanja Petnicki-Ocwieja; Aurelie Kern; Tess L Killpack; Stephen C Bunnell; Linden T Hu
Journal:  J Immunol       Date:  2015-09-30       Impact factor: 5.422

2.  TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia.

Authors:  Kevin G Burfeind; Xinxia Zhu; Peter R Levasseur; Katherine A Michaelis; Mason A Norgard; Daniel L Marks
Journal:  Brain Behav Immun       Date:  2018-05-28       Impact factor: 7.217

3.  Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection.

Authors:  Charlotte Odendall; Andrew A Voak; Jonathan C Kagan
Journal:  J Immunol       Date:  2017-09-27       Impact factor: 5.422

Review 4.  Microbe-inducible trafficking pathways that control Toll-like receptor signaling.

Authors:  Yunhao Tan; Jonathan C Kagan
Journal:  Traffic       Date:  2016-11-23       Impact factor: 6.215

5.  Chronic ethanol consumption: role of TLR3/TRIF-dependent signaling.

Authors:  Gizelle M McCarthy; Anna S Warden; Courtney R Bridges; Yuri A Blednov; R Adron Harris
Journal:  Addict Biol       Date:  2017-08-25       Impact factor: 4.280

6.  An alternative model for type I interferon induction downstream of human TLR2.

Authors:  Timo Oosenbrug; Michel J van de Graaff; Mariëlle C Haks; Sander van Kasteren; Maaike E Ressing
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

7.  MicroRNA-33 Regulates the Innate Immune Response via ATP Binding Cassette Transporter-mediated Remodeling of Membrane Microdomains.

Authors:  Lihua Lai; Kathleen M Azzam; Wan-Chi Lin; Prashant Rai; Julie M Lowe; Kristin A Gabor; Jennifer H Madenspacher; Jim J Aloor; John S Parks; Anders M Näär; Michael B Fessler
Journal:  J Biol Chem       Date:  2016-07-28       Impact factor: 5.157

Review 8.  Space and time: New considerations about the relationship between Toll-like receptors (TLRs) and type I interferons (IFNs).

Authors:  Darren J Perkins; Stefanie N Vogel
Journal:  Cytokine       Date:  2015-03-25       Impact factor: 3.861

9.  Pam2CSK4 and Pam3CSK4 induce iNOS expression via TBK1 and MyD88 molecules in mouse macrophage cell line RAW264.7.

Authors:  Panthong Kulsantiwong; Matsayapan Pudla; Chanya Srisaowakarn; Jitrada Boondit; Pongsak Utaisincharoen
Journal:  Inflamm Res       Date:  2017-06-07       Impact factor: 4.575

Review 10.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.